Drug details

Wixela Inhub (fluticasone propionate and salmeterol inhalation powder)

type of Respiratory Inhalant Combos, Respiratory Inhalant Combos, COPD Agents

Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) contains a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) indicated for twice-daily treatment of asthma in patients aged 4 years and older or maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). Wixela Inhub is available in generic form.

The drug is often used to treat Asthma , Chronic obstructive pulmonary disease .

This drug may have the following side effects:

• worsening breathing problems,
• needing your rescue inhaler more frequently,
• peak flow meter results decrease

The following drugs are related to Wixela Inhub, either as a replacement or used together:

• Advair Diskus (fluticasone propionate)
• Advair HFA (fluticasone propionate and salmeterol)
• Airsupra (albuterol and budesonide inhalation aerosol, for oral inhalation)
• Albuterol Sulfate (albuterol sulfate inhalation solution)
• Ventolin HFA (albuterol sulfate inhalation aerosol)
• Ventolin Solution (albuterol sulfate inhalation solution)
• Ventolin Syrup (albuterol sulfate syrup)
• Asmanex (mometasone furoate)
• Asmanex Twisthaler (mometasone furoate inhalation powder)
• Flovent (fluticasone propionate)
• Flovent Diskus (fluticasone propionate)
• Flovent HFA (fluticasone propionate hfa)
• Singulair (montelukast sodium)
• Tezspire (tezepelumab-ekko injection, for subcutaneous use)